You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FGFR genomic alteration

Showing 1 - 25 of 2,252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Intrahepatic Cholangiocarcinoma Trial (derazantinib)

Available
  • Intrahepatic Cholangiocarcinoma
  • (no location specified)
Jan 13, 2023

Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)

Recruiting
  • Advanced or Recurrent Solid Tumors
  • FGFR Gene Alterations
  • Aoba-ku, Sendai, Miyagi, Japan
  • +4 more
May 9, 2022

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Genomic Alteration in Luminal A or Luminal B Subtypes

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022

    Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

    Recruiting
    • Cholangiocarcinoma
    • +4 more
    • Anchorage, Alaska
    • +16 more
    Jan 3, 2023

    NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • Los Angeles, California
    • +41 more
    Jun 27, 2022

    Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

    Recruiting
    • Locally Advanced Gastrointestinal Stromal Tumor
    • +7 more
    • Biopsy
    • +4 more
    • Duarte, California
    • +17 more
    Feb 2, 2023

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Soft Tissue Sarcoma Trial in France (drug, combination product, other)

    Recruiting
    • Soft Tissue Sarcoma
    • Bordeaux, France
    • +17 more
    Oct 4, 2022

    NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Avignon, France
    • +36 more
    Jul 29, 2022

    Solid Tumours Trial in Worldwide (Debio1347 (CH5183284))

    Terminated
    • Solid Tumours
    • Debio1347 (CH5183284)
    • Boston, Massachusetts
    • +7 more
    Sep 8, 2020

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

    Recruiting
    • Bladder Carcinoma
    • +7 more
    • Atezolizumab
    • +5 more
    • Toronto, Ontario, Canada
      University Health Network Princess Margaret Cancer Center LAO
    Nov 8, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (FGFR Inhibitor

    Completed
    Has Results
    • Advanced Lymphoma
    • +5 more
    • FGFR Inhibitor AZD4547
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 8, 2021

    Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • La Jolla, California
    • +4 more
    Aug 9, 2022

    Metastatic Cancers Trial in France (Blood sampling)

    Completed
    • Metastatic Cancers
    • Blood sampling
    • Amiens, France
    • +35 more
    Sep 5, 2022

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Birmingham, Alabama
    • +125 more
    Nov 21, 2022

    Renal Pelvis and Ureter Urothelial Carcinoma Trial in Houston (drug, other, procedure)

    Active, not recruiting
    • Renal Pelvis and Ureter Urothelial Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 21, 2022

    Solid Tumor, Unspecified, Adult Trial in Villejuif (Biopsy)

    Recruiting
    • Solid Tumor, Unspecified, Adult
    • Biopsy
    • Villejuif, Val De Marne, France
      Gustave Roussy Cancer Campus Grand Paris
    Sep 3, 2021

    Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Newly obtained biopsy and Blood samples collection
    • Bayonne, France
    • +5 more
    Feb 1, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Alteration of Symbiosis Intestinal Microbiota on Anorexia

    Not yet recruiting
    • Anorexia Nervosa
    • +2 more
    • Stool sample
    • Villejuif, France
      Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)
    Nov 21, 2022

    Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)

    Unknown status
    • Malignant Neoplasm
    • ponatinib hydrochloride
    • laboratory biomarker analysis
    • Ann Arbor, Michigan
    • +1 more
    Feb 14, 2020

    Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

    Recruiting
    • Breast Cancer
    • +3 more
    • Ancona, Italy
    • +40 more
    Jan 25, 2023

    Brain Metastases Trial (biological samples (blood test and lumbar puncture))

    Not yet recruiting
    • Brain Metastases
    • biological samples (blood test and lumbar puncture)
    • (no location specified)
    May 4, 2023